Acute rejection after liver transplantation is less common, but predicts better prognosis in HBV-related hepatocellular carcinoma patients

Background With a novel finding of significantly lower incidence of acute rejection (AR) in patients with hepatocellular carcinoma (HCC) after liver transplantation, compared with those with benign end-stage liver disease (BESLD), in a large national cohort, we analyzed the correlations among the pe...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Hepatology international 2020-05, Vol.14 (3), p.347-361
Hauptverfasser:	Mao, Jia-Xi, Guo, Wen-Yuan, Guo, Meng, Liu, Cong, Teng, Fei, Ding, Guo-Shan
Format:	Artikel
Sprache:	eng
Schlagworte:	Albumins Arsenic Aspartate aminotransferase C-reactive protein Carcinoma, Hepatocellular - immunology Carcinoma, Hepatocellular - pathology Carcinoma, Hepatocellular - surgery CD25 antigen CD4 antigen CD8 antigen China - epidemiology Colorectal Surgery Correlation analysis End Stage Liver Disease - surgery Etiology Female Fibrinogen Graft rejection Graft Rejection - epidemiology Graft Rejection - etiology Hepatitis Hepatitis B Hepatocellular carcinoma Hepatology Humans Immunocompromised Host Immunoregulation Immunosuppression Incidence Inflammation Interleukin 10 Interleukin 2 Liver Liver cancer Liver diseases Liver Neoplasms - immunology Liver Neoplasms - pathology Liver Neoplasms - surgery Liver transplantation Liver Transplantation - adverse effects Liver Transplantation - methods Liver transplants Lymphocytes Lymphocytes T Male Medical prognosis Medicine Medicine & Public Health Middle Aged Monitoring, Immunologic - methods Monitoring, Immunologic - statistics & numerical data Monocytes Neoplasm Staging Original Article Outcome and Process Assessment, Health Care Platelets Prognosis Rejection Risk analysis Risk factors Surgery Survival Survival Analysis Transplantation Tumors Viruses γ-Interferon
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!